RoosterBio
Developer of human mesenchymal stem cells and extracellular vesicles. The company specializes in human bone marrow-derived and adipose-derived MSCs and associated, highly-engineered media formulations for the expansion of these cells. Founded in 2012, headquartered in Frederick, United States. The company has raised $38.4M in funding at the series b stage. The team comprises 58 (Jun 30, 2026) employees. RoosterBio…
Funding snapshot
About
Developer of human mesenchymal stem cells and extracellular vesicles. The company specializes in human bone marrow-derived and adipose-derived MSCs and associated, highly-engineered media formulations for the expansion of these cells. Founded in 2012, headquartered in Frederick, United States. The company has raised $38.4M in funding at the series b stage. The team comprises 58 (Jun 30, 2026) employees. RoosterBio operates in the Life Sciences Platforms and Tools, Cell Therapy, Genomics sectors. The company focuses on Bioreagents, Cell Culture. Notable investors include Maryland Stem Cell Research Fund, Vanedge Capital, Dynamk Capital, Planetary Technologies, HHS, TEDCO. The company has a team of 58 employees.
Business model
Genomics > Enabling Technologies > Kits and Reagents > Bioreagents,
Life Sciences Platforms and Tools > Research Reagents and Kits > Cell Culture
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.